Research and Clinical Trials

Mayo Clinic researchers report that having a history of cancer or coronary artery disease may actually reduce the risk of dementia.

Researchers have identified a gene marker that may lead to a more effective, precision treatment for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer.

A new blog series to raise awareness about clinical trials and their important role in cancer care.

Mayo Clinic Comprehensive Cancer Center has been awarded a five-year, $12.1 million Specialized Program of Research Excellence (SPORE) grant in breast cancer from the National Cancer Institute (NCI).

Lewis Roberts, M.B., Ch.B., Ph.D., and Essa Mohamed, Ph.D., discuss their research and what they hope to achieve through their work to close the gap in health disparities.

Research revealed DNA sequences associated with response to abiraterone acetate to identify additional treatments for men with advanced prostate cancer resistant to standard therapies.

Mayo Clinic researchers are working to develop personalized therapeutic cancer vaccines that could potentially target each person's distinctive tumor characteristics.

Researchers developed an algorithm to improve the prediction of colorectal cancer recurrence.

Dr. Andrew Feldman and his team are helping to redefine the classification of T-cell lymphomas, an often fatal group of immune system tumors.

Dr. Reona Sakemura is researching treatment resistance mechanisms in multiple myeloma to make immunotherapy more effective.